Precision 're'arming of CD33 antibodies

被引：1
|
作者：
Borthakur, Gautam [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2013年 / 122卷 / 08期
关键词：
CELLS;
D O I：
10.1182/blood-2013-06-509638
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [41] Characterization of antibodies against ferret immunoglobulins, cytokines and CD markers
    Martel, Cyril Jean-Marie
    Aasted, Bent
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2009, 132 (2-4) : 109 - 115
  • [42] Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
    Scodeller, Pablo
    Simon-Gracia, Lorena
    Kopanchuk, Sergei
    Tobi, Allan
    Kilk, Kalle
    Saalik, Pille
    Kurm, Kaarel
    Squadrito, Mario Leonardo
    Kotamraju, Venkata Ramana
    Rinken, Ago
    De Palma, Michele
    Ruoslahti, Erkki
    Teesalu, Tambet
    SCIENTIFIC REPORTS, 2017, 7
  • [43] Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic Window
    Satomaa, Tero
    Pynnoenen, Henna
    Aitio, Olli
    Hiltunen, Jukka O.
    Pitkanen, Virve
    Laehteenmaeki, Tuula
    Kotiranta, Titta
    Heiskanen, Annamari
    Haenninen, Anna-Liisa
    Niemela, Ritva
    Helin, Jari
    Kuusanmaki, Heikki
    Vanttinen, Ida
    Rathod, Ramji
    Nieminen, Anni I.
    Yatkin, Emrah
    Heckman, Caroline A.
    Kontro, Mika
    Saarinen, Juhani
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (08) : 1073 - 1083
  • [44] Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
    Rossi, Edmund A.
    Goldenberg, David M.
    Cardillo, Thomas M.
    Stein, Rhona
    Chang, Chien-Hsing
    BLOOD, 2009, 113 (24) : 6161 - 6171
  • [45] CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia
    Li, Hong
    Xu, Songlin
    Quan, Jishan
    Yung, Bryant C.
    Pang, Jiuxia
    Zhou, Chenguang
    Cho, Young-Ah
    Zhang, Mengzi
    Liu, Shujun
    Muthusamy, Natarajan
    Chan, Kenneth K.
    Byrd, John C.
    Lee, L. James
    Marcucci, Guido
    Lee, Robert J.
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 2010 - 2018
  • [46] Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer
    Pellizzari, Giulia
    Bax, Heather J.
    Josephs, Debra H.
    Gotovina, Jelena
    Jensen-Jarolim, Erika
    Spicer, James F.
    Karagiannis, Sophia N.
    TRENDS IN MOLECULAR MEDICINE, 2020, 26 (06) : 615 - 626
  • [47] The Identification of Cherry Valley Ducks CD8+Lymphocytes by Using Homo sapiens CD8 Antibodies
    Bai, J. Y.
    Li, W.
    Li, S.
    Zhang, W. P.
    Gu, C. Q.
    Hu, X. Y.
    Cheng, G. F.
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2011, 10 (19): : 2516 - 2522
  • [48] The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies
    Pilch, Zofia
    Tonecka, Katarzyna
    Skorzynski, Marcin
    Sas, Zuzanna
    Braniewska, Agata
    Kryczka, Tomasz
    Boon, Louis
    Golab, Jakub
    Meyaard, Linde
    Rygiel, Tomasz P.
    PLOS ONE, 2019, 14 (01):
  • [49] CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
    Sun, Jennifer
    Chen, Yixuan
    Lubben, Berit
    Adebayo, Ola
    Muz, Barbara
    Azab, Abdel Kareem
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [50] Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies
    Lu, Quansheng
    Chen, Xi
    Wang, Shan
    Lu, Yu
    Yang, Chunsheng
    Jiang, Guan
    ONCOTARGETS AND THERAPY, 2020, 13 : 9323 - 9331
12345